Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biden dex bill expected

This article was originally published in The Tan Sheet

Executive Summary

A bill from Sen. Joe Biden, D-Del., that would place an age restriction of 18 on OTC sales of dextromethorphan is likely to be introduced before the August recess. The bill will not include language establishing pre-emption over potential state bills with greater restrictions, according to staffers, but will include funding for abuse prevention education efforts. Biden has worked with input from manufacturers and retailers (1"The Tan Sheet" March 12, 2007, p. 3). The bill will also address abuse of bulk DXM...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100651

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel